Backing startups building software for biotech and life-science operations.

What we back

AI is changing how biotech products are designed. We back the software for the steps that follow: from model to molecule, and from molecule to margins.

• Lab data and infrastructure. Platforms that capture experiments and instrument output in a form both scientists and models can use.
• Lab automation and orchestration. Software that plans, runs and tracks experiments across instruments, robotic workcells and cloud labs.
• AI for design and development. Tools for protein and ligand design, formulation and process development.
• Manufacturing and quality. Software for manufacturing execution, batch records and quality, where a validated design becomes a product.

How we invest

We invest at pre-seed and seed. We judge a product the way the lab or plant that buys it will: by the work it changes, how it fits their systems and what it takes to pass validation. Founders work directly with the person who makes the investment decision. Learn more about the firm.

Two markets

The US is our home market, and we also back Nordic founders in Denmark, Sweden, Norway and Finland. The bridge runs both ways: we help Nordic companies land US customers and investors, and US companies reach buyers in Europe.

Research

We publish our research in the open: the evidence behind our thesis and the questions we're still working through. Explore our research.